Peptide Elongation Factors [elongační faktory]
topical
13
- Terms
-
elongační faktor
peptidy - elongační faktory
-
Elongation Factor
Persistent link
https://www.medvik.cz/link/D010445
Definition
Protein factors uniquely required during the elongation phase of protein synthesis.
- Annotation
- /drug eff /biosyn /physiol /ultrastruct permitted
- DUI
- D010445 MeSH Browser
- CUI
- M0016222
- Previous indexing
- Peptides (1966-1972); Proteins (1966-1972); Bacterial Proteins (1966-1972)
- History note
- 73
- Public note
- 73
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AG
- agonists 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BI
- biosynthesis 1
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 8
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 1
- EC
- economics 0
- GE
- genetics 3
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 1
- ME
- metabolism 3
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 4
- TO
- toxicity 0
- UL
- ultrastructure 1
- UR
- urine 0
...
Occurrences in Medvik records
D
Chemicals and Drugs
D12.776.835.700.350
GTP Phosphohydrolase-Linked Elongation Factors
D12.776.835.965
Ribosomal Protein L3
D12.776.835.982
Ribosomal Protein S9